• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸克林沙星的体外抗菌活性,一种新型氟喹诺酮类抗生素。

In vitro antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.

机构信息

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.

出版信息

Chemotherapy. 2012;58(3):175-84. doi: 10.1159/000337084. Epub 2012 Jun 14.

DOI:10.1159/000337084
PMID:22699239
Abstract

BACKGROUND

Chinfloxacin is a novel synthetic fluoroquinolone with a structure similar to moxifloxacin. The in vitro activity of chinfloxacin was evaluated in the current study.

METHOD

Chinfloxacin was tested against a total of 1,739 clinical isolates representing 23 species using the agar dilution method. Studies of bactericidal activity, including minimum bactericidal concentrations (MBC) and time-kill curve determinations, were conducted according to the recommendations of the Clinical and Laboratory Standards Institute.

RESULTS

Minimum inhibitory concentrations (MIC)(50)s and MIC(90)s of chinfloxacin were found to be the same or 2-fold lower than those of moxifloxacin against gram-positive isolates except for Streptococcus pyogenes (against which chinfloxacin showed similar MIC(50) as moxifloxacin but 2-fold higher MIC(90)), and the same as or 2-fold higher than those of moxifloxacin against gram-negative isolates. Chinfloxacin showed potent bactericidal activity with MBC/MIC ratios in the range of 1-2 for almost all the isolates tested. Time-kill curves further demonstrated chinfloxacin as a concentration-dependent bactericidal agent usually effective at concentrations of 2 MIC or higher.

CONCLUSION

Chinfloxacin showed similar in vitro activity as moxifloxacin.

摘要

背景

盐酸克林沙星是一种新型合成氟喹诺酮类药物,其结构与莫西沙星相似。本研究评估了盐酸克林沙星的体外活性。

方法

采用琼脂稀释法对代表 23 种细菌的 1739 株临床分离株进行了盐酸克林沙星的检测。根据临床和实验室标准协会的建议,进行了杀菌活性研究,包括最小杀菌浓度(MBC)和时间杀伤曲线测定。

结果

盐酸克林沙星对革兰阳性菌的 MIC(50)和 MIC(90)与莫西沙星相同或低 2 倍,除了对化脓性链球菌(盐酸克林沙星对其的 MIC(50)与莫西沙星相同,但 MIC(90)高 2 倍),与莫西沙星对革兰阴性菌的 MIC(50)和 MIC(90)相同或低 2 倍。盐酸克林沙星对几乎所有受试分离株均具有较强的杀菌活性,MBC/MIC 比值在 1-2 之间。时间杀伤曲线进一步表明,盐酸克林沙星是一种浓度依赖性杀菌剂,在 2 倍 MIC 或更高浓度时通常有效。

结论

盐酸克林沙星的体外活性与莫西沙星相似。

相似文献

1
In vitro antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.盐酸克林沙星的体外抗菌活性,一种新型氟喹诺酮类抗生素。
Chemotherapy. 2012;58(3):175-84. doi: 10.1159/000337084. Epub 2012 Jun 14.
2
Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.含有手性 3-(烷氧基亚氨基)-2-(氨甲基)氮杂环丁烷部分的氟喹诺酮衍生物的设计、合成及体外抗菌活性。
ChemMedChem. 2012 Jul;7(7):1230-6. doi: 10.1002/cmdc.201200210. Epub 2012 May 25.
3
In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.莫西沙星对台湾常见临床分离菌株的体外活性。
J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.
4
In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens.新型氟喹诺酮类药物 WQ-3810 对多重耐药和氟喹诺酮类耐药病原体的体外活性。
Int J Antimicrob Agents. 2014 Nov;44(5):443-9. doi: 10.1016/j.ijantimicag.2014.07.017. Epub 2014 Sep 1.
5
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.新型抗菌药物 XF-73 对敏感和耐药的革兰阳性和革兰阴性细菌的体外活性。
Int J Antimicrob Agents. 2010 Jun;35(6):531-6. doi: 10.1016/j.ijantimicag.2010.02.008. Epub 2010 Mar 25.
6
In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.体内抗菌活性的盐酸沙拉沙星,一种新型氟喹诺酮类抗生素。
J Antimicrob Chemother. 2012 Apr;67(4):955-61. doi: 10.1093/jac/dkr557. Epub 2011 Dec 29.
7
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.通过药敏试验和时间杀菌试验比较加替沙星与其他药物对金黄色葡萄球菌、化脓性链球菌及呼吸道病原体的活性。
J Antimicrob Chemother. 2003 Nov;52(5):869-72. doi: 10.1093/jac/dkg429. Epub 2003 Sep 30.
8
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia.JNJ-Q2 的活性研究,一种新型氟喹诺酮类药物,针对从社区获得性细菌性肺炎患者分离的当代病原体进行测试。
Int J Antimicrob Agents. 2012 Apr;39(4):321-5. doi: 10.1016/j.ijantimicag.2011.11.016. Epub 2012 Feb 4.
9
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates.新型肠外头孢菌素BAL9141对当代革兰氏阳性菌和革兰氏阴性菌分离株的杀菌活性。
Diagn Microbiol Infect Dis. 2004 Sep;50(1):73-5. doi: 10.1016/j.diagmicrobio.2004.04.011.
10
Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.脱羧氟喹诺酮类的制备及抗菌评价。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5961-3. doi: 10.1016/j.bmcl.2011.07.060. Epub 2011 Jul 29.

引用本文的文献

1
Investigational antimicrobial agents of 2013.2013 年的研究性抗菌药物。
Clin Microbiol Rev. 2013 Oct;26(4):792-821. doi: 10.1128/CMR.00033-13.